Physitrack PLC (PTRK.ST)
SEK 13.9
(-1.8%)
SEK 13.9
(-1.8%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.44 Million EUR | 3046.14% |
| 2022 | 109.38 Thousand EUR | -89.38% |
| 2021 | 1.03 Million EUR | 12.41% |
| 2020 | 916.71 Thousand EUR | 557.82% |
| 2019 | -200.23 Thousand EUR | -23.66% |
| 2018 | -161.93 Thousand EUR | -136.19% |
| 2017 | 447.41 Thousand EUR | 88.33% |
| 2016 | 237.56 Thousand EUR | 155.26% |
| 2015 | -429.89 Thousand EUR | -179.05% |
| 2014 | -154.05 Thousand EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -25.62 Thousand EUR | -100.67% |
| 2024 Q2 | -442.87 Thousand EUR | -1628.44% |
| 2023 Q4 | 3.8 Million EUR | 3946.51% |
| 2023 Q1 | 113.74 Thousand EUR | -76.16% |
| 2023 Q2 | -188.46 Thousand EUR | -265.69% |
| 2023 Q3 | -98.94 Thousand EUR | 47.5% |
| 2023 FY | 3.44 Million EUR | 3046.14% |
| 2022 Q3 | 2789.00 EUR | 100.88% |
| 2022 Q1 | 410.84 Thousand EUR | 16.29% |
| 2022 FY | 109.38 Thousand EUR | -89.38% |
| 2022 Q4 | 477.14 Thousand EUR | 17008.25% |
| 2022 Q2 | -316.6 Thousand EUR | -177.06% |
| 2021 Q1 | 300.77 Thousand EUR | -10.33% |
| 2021 FY | 1.03 Million EUR | 12.41% |
| 2021 Q4 | 353.28 Thousand EUR | 458.02% |
| 2021 Q3 | 63.31 Thousand EUR | 106.07% |
| 2021 Q2 | -1.04 Million EUR | -446.97% |
| 2020 FY | 916.71 Thousand EUR | 557.82% |
| 2020 Q4 | 335.44 Thousand EUR | -17.08% |
| 2020 Q3 | 404.54 Thousand EUR | 84.59% |
| 2020 Q2 | 219.15 Thousand EUR | 660.89% |
| 2020 Q1 | -39.07 Thousand EUR | 0.0% |
| 2019 FY | -200.23 Thousand EUR | -23.66% |
| 2018 FY | -161.93 Thousand EUR | -136.19% |
| 2017 FY | 447.41 Thousand EUR | 88.33% |
| 2016 FY | 237.56 Thousand EUR | 155.26% |
| 2015 FY | -429.89 Thousand EUR | -179.05% |
| 2014 FY | -154.05 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aino Health AB (publ) | -9.51 Million SEK | 136.176% |
| Bonzun AB (publ) | -25.25 Million SEK | 113.627% |
| Kontigo Care AB (publ) | 52 Thousand SEK | -6518.2% |
| Medhelp Care Aktiebolag (publ) | -10.48 Million SEK | 132.826% |
| RaySearch Laboratories AB (publ) | 114.88 Million SEK | 97.004% |
| Surgical Science Sweden AB (publ) | 191.28 Million SEK | 98.201% |